BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 339329)

  • 1. Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt).
    Jönsson G; Högberg B; Nilsson T
    Scand J Urol Nephrol; 1977; 11(3):231-8. PubMed ID: 339329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results with estramustine phosphate (NSC-89199): a comparison of the intravenous and oral preparations.
    Nilsson T; JONSSON G
    Cancer Chemother Rep; 1975; 59(1):229-32. PubMed ID: 1093671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of advanced carcinoma of the prostate with Estracyt (author's transl)].
    Nagel R; Kölln CP
    Med Klin; 1976 Oct; 71(41):1724-8. PubMed ID: 824540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate.
    Mittelman A; Shukla SK; Welvaart K; Murphy GP
    Cancer Chemother Rep; 1975; 59(1):219-23. PubMed ID: 1093669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD; O'Donoghue EP; Kennedy CL
    Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended therapy of stage D carcinoma of the prostate with oral estramustine phosphate.
    Mittelman A; Shukla SK; Murphy GP
    J Urol; 1976 Apr; 115(4):409-12. PubMed ID: 1263317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of prostatic cancer with Estracyt (estramustine phosphate).
    Balogh F; Kisbenedek L
    Int Urol Nephrol; 1975; 7(2):135-40. PubMed ID: 1102475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F; Esposti PL; Andersson L
    Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
    Murphy GP; Slack NH; Mittelman A
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):34-42. PubMed ID: 6364365
    [No Abstract]   [Full Text] [Related]  

  • 11. [The phase IV studies with Estracyt in prostatic cancer].
    Ohhori T; Kubo T; Akasaka T; Funyu T; Yagihashi Y; Kudo T; Tsuchida S; Harada T; Sasaki S; Orikasa S
    Hinyokika Kiyo; 1988 Aug; 34(8):1493-502. PubMed ID: 3057833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L; Edsmyr F; Jönsson G; Könyves I
    Recent Results Cancer Res; 1977; (60):73-7. PubMed ID: 866798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A; Morvay J; Vécsei B
    Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced carcinoma of the prostate with Estracyt.
    Nagel R; Kölln CP
    Prog Clin Biol Res; 1976; 6():267-84. PubMed ID: 1023214
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Fritjofsson A; Norlén BJ; Högberg B; Rajalakshmi M; Cekan SZ; Diczfalusy E
    Scand J Urol Nephrol; 1981; 15(1):37-44. PubMed ID: 6787701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 17. Estramustine phosphate: a specific chemotherapeutic agent?
    Von Hoff DD; Rozencweig M; Slavik M; Muggia FM
    J Urol; 1977 Apr; 117(4):464-6. PubMed ID: 850319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative treatment with oral Estracyte in disseminated prostatic carcinoma.
    Welvaart K
    Arch Chir Neerl; 1975; 27(3):193-8. PubMed ID: 55103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estracyt treatment in prostatic neoplasms].
    Sander S
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):27-8. PubMed ID: 1257949
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study of estramustine phosphate disodium (Estracyt) on prostatic cancer--results of long-term therapy for 38 patients with prostatic cancer].
    Asakawa M; Wada S; Hayahara N; Yayumoto R; Kishimoto T; Maekawa M; Morikawa Y; Kawakita J; Umeda M; Horii A
    Hinyokika Kiyo; 1990 Nov; 36(11):1361-9. PubMed ID: 2288316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.